Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated persons and legal entities

PrintIncrease text size
Release date: 18-08-2008
Release time: 09:23


H. Lundbeck A/S hereby reports transactions made by executives and persons and legal entities closely associated to them with shares in H. Lundbeck A/S and linked securities, cf. section 28a of the Danish Securities Trading Act.
The list is based on reports received by H. Lundbeck A/S from the company's executives today or yesterday.
 
Name:
 
Ulf Arne Wiinberg
Job position of the executive:
 
President and CEO
Relation to executive (associated person or legal entity):
 
ID code (ISIN code):
 
DK 0010287234
Description of the security:
 
Share
Nature of the transaction:
 
Purchase of Share
Date of trading:
 
14 August 2008
 
Market on which the trading was effected:
Copenhagen Stock Exchange
Number of traded securities:
 
4,000
pcs.
Market price of securities traded:
 
457,000
DKK
 
  
Persons/entities under an obligation to report
Persons or entities under an obligation to report are defined as members of the Executive Management and the Supervisory Board of H. Lundbeck A/S and persons/entities closely associated to them.
 
Closely associated persons/entities means inter alia:
  •            spouse or cohabitant
  •            children below the age of 18
  •            legal entities in which the insider has a controlling influence
    •  
    The content of this release will have no influence on the Lundbeck Group's financial result for 2008.
     
    Lundbeck contacts
     
    Investors:
    Media:
     
     
    Jacob Tolstrup
    Jens Harder Højbjerg
    Director
    Media Relations Manager
    +45 36 43 30 79
    +45 36 43 28 33
     
     
    Palle Holm Olesen
     
    Head of Investor Relations
     
    +45 36 43 24 26
     
     
    Stock Exchange Release No 353 - 18 August 2008
     
    About Lundbeck
    H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.5 billion or USD 2.0 billion). The number of employees is approx. 5,300 globally. For more information, please visit www.lundbeck.com.
    H. Lundbeck AB
    Tel
    +46 42 25 43 00
    Rundgången 30 B
    Orgnr.
    556039-8462
    P.O.Box 23
    email
    Specialister i psykiatri och pionjärer i neurologi
    Villkor och upphovsrätt
    		Kvalitetsmärkning; 2005-08-17. Länk till LIFs kvalitetsmärkningssida för webbplatsen www.lundbeck.se